Lymphoma
Lymphoma is a cancer of the lymphatic system that affects white blood cells. Explore the different types, including Hodgkin and non-Hodgkin lymphoma, along with cutting-edge treatments and research.
12 new breakthroughs in the fight against cancer
Cancer is one of the worldÕs biggest killers, with around 10 million deaths per year due to the disease.
Novel nanomotors could improve bladder cancer immunotherapy
A research team has developed an innovative nanomotor-based strategy to improve immunotherapy for bladder cancer. The study, published in the journal Nature Communications, offers a promising alternative to the limitations of existing treatments. The research was led by the Institute for Bioengineering of Catalonia (IBEC) and Pohang University of Science and Technology (POSTECH) in South Korea.
This Diet Increases Brain Cancer Survival By 66%, Study Finds
Glioblastoma multiforme (GBM) is one of the most aggressive and deadly brain cancers, with a median survival rate of just 12 to 18 months despite surgery, chemotherapy, and radiation. But a recent clinical study1 has uncovered a promising alternative
New Hope For Bladder Cancer Patients Like Broadcaster Terry Bradshaw; Saving The Bladder & Avoiding Cancer Spread With A New Protocol
An ongoing clinical trial is suggesting that a certain type of treatment for muscle-invasive bladder cancer—noadjuvant chemoimmunotherapy followed by risk-adapted therapy—offered better rates of metastasis-free survival and helped patients keep their bladders.
Moffitt Cancer Center Announces New Proton Therapy Treatment
Moffitt Cancer Center has introduced a new proton therapy treatment, offering advanced options for cancer patients.
Combination of dual-targeted therapies and chemotherapy shows high response rates in BRAF-mutated metastatic colorectal cancer
Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefitted from first-line treatment with the targeted therapies encorafenib and cetuximab plus a mFOLFOX6 chemotherapy regimen, according to results from the Phase III BREAKWATER trial led by researchers at The University of Texas MD Anderson Cancer Center.
Safdarjung Hospital offers CAR-T cell therapy
Delhi’s Safdarjung Hospital has successfully treated a patient with refractory Non-Hodgkin lymphoma using Chimeric Antigen Receptor T-cell (CAR-T) therapy. With this, Safdarjung has become India’s first hospital to provide the advanced immunotherapy. It has also set a new standard for cancer care in public hospitals. CAR-T cell therapy, an innovative form of treatment, harnesses the […]
Pfizer Inc. showcases groundbreaking genitourinary cancer research at ASCO GU Symposium
Pfizer presented new research on treatments for genitourinary cancers at the ASCO GU Symposium, highlighting advancements in oncology.
Cancer breakthrough: New jab could slash risk of cervical cancer
More than half of those given a new vaccine in a clinical trial saw their pre-cancerous cells destroyed
